These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19296423)

  • 41. [Adolescents with cancer - administrative, clinical and scientific implications].
    Göbel U; Creutzig U; Klingebiel T; Kaatsch P; Niehues T; Körholz D
    Klin Padiatr; 2011 Nov; 223(6):311-4. PubMed ID: 22052629
    [No Abstract]   [Full Text] [Related]  

  • 42. [Creation of centres in high-volume hospitals -- promotor of communication].
    Möbius C; Schumacher G
    Zentralbl Chir; 2013 Feb; 138(1):53-6. PubMed ID: 22614230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Certification of colorectal cancer units -- a critical overview on the basis of unsettled aspects].
    Klaue HJ
    Zentralbl Chir; 2013 Feb; 138(1):38-44. PubMed ID: 22083348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Does structural and process quality of certified prostate cancer centers result in better medical care?].
    Kranz J; Grundmann RT; Steffens JA
    Urologe A; 2021 Jan; 60(1):59-66. PubMed ID: 32876699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
    Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Specialised treatment of colorectal cancer in certified cancer centres: Do patients really have to travel further?].
    Berger E; Reichebner C; Eriksen A; Hildebrandt M; Kuklinski D; Busse R
    Gesundheitswesen; 2023 Jul; 85(7):657-666. PubMed ID: 37321253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis.
    Bierbaum V; Schmitt J; Klinkhammer-Schalke M; Schoffer O
    Gesundheitswesen; 2023 Sep; 85(S 03):S197-S204. PubMed ID: 37751756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A chance for improved nursing care for extremely low birth weight infants missed!].
    Eglin K
    Kinderkrankenschwester; 2011 Mar; 30(3):105. PubMed ID: 21485046
    [No Abstract]   [Full Text] [Related]  

  • 49. [Not Available].
    Steinbrück R
    Aktuelle Urol; 2015 May; 46(3):215. PubMed ID: 26077304
    [No Abstract]   [Full Text] [Related]  

  • 50. [Accessibility of organ cancer centres: is there already nation-wide coverage in Germany?].
    Lewers D; Geraedts M
    Gesundheitswesen; 2015 Jan; 77(1):24-30. PubMed ID: 24566838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinic mergers and cartel law].
    Klaue S
    Chirurg; 2006 Nov; Suppl():342-4. PubMed ID: 17598268
    [No Abstract]   [Full Text] [Related]  

  • 52. [Amendment of the structural quality for inpatient rheumatology. A forward-looking concept].
    Lakomek HJ; Braun J; Gromnica-Ihle E; Fiehn C; Claus S; Specker C; Jung J; Krause A; Lorenz HM; Robbers J
    Z Rheumatol; 2011 Sep; 70(7):615-9. PubMed ID: 21858486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The Dusseldorf Urology Network. An economic association as an alternative to the national health program organization].
    Rulf W
    Urologe A; 2003 Mar; 42(3):436-40. PubMed ID: 12723547
    [No Abstract]   [Full Text] [Related]  

  • 54. [Why Certification of Colorectal Cancer Centres Does Not Improve Surgical Quality].
    Vogel PA
    Zentralbl Chir; 2019 Jun; 144(3):273-280. PubMed ID: 29986354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The follow-up of PSA tests for the early detection of prostate cancer. The responsibility of the physician to explain treatment methods which are not covered by public health insurance plans].
    Cramer R; Dahm FJ
    Urologe A; 2005 Jul; 44(7):798-800. PubMed ID: 15891867
    [No Abstract]   [Full Text] [Related]  

  • 56. Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification.
    Follmann M; Schadendorf D; Kochs C; Buchberger B; Winter A; Wesselmann S
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):139-47. PubMed ID: 24238575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guideline-Based Quality Indicators for Kidney and Bladder Cancer in Germany: Development and Implementation.
    Rückher J; Lobitz J; Follmann M; Derenz S; Schmidt S; Mensah J; Wesselmann S
    Urol Int; 2022; 106(4):360-367. PubMed ID: 34384078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG).
    Stuebs FA; Beckmann MW; Fehm T; Dannecker C; Follmann M; Langer T; Wesselmann S
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12755-12764. PubMed ID: 37452203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Benchmarking: how to measure outcome quality at the comprehensive oncology centre in Stuttgart].
    Meisner C; Brinkmann F; Henke D; Junack C; Faisst S; Heidemann E
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):365-70. PubMed ID: 21767795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Guideline and medical standard].
    Ulsenheimer K
    Versicherungsmedizin; 2015 Jun; 67(2):87-9. PubMed ID: 26281290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.